Ernexa Therapeutics (ERNA) Selling, General & Administrative (2009 - 2026)
Ernexa Therapeutics (ERNA) recorded Selling, General & Administrative of $1.31 million in Q2 2026, down 3.9% from $1.37 million a year earlier and down 19.6% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a TTM basis, Ernexa Therapeutics' Selling, General & Administrative came in at $5.32 million as of Jun 30, 2026, down 31.0% year-over-year; for FY2025, it was $5.16 million, down 60.7% from FY2024.
- Annual Selling, General & Administrative has declined for three straight years, though with a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $13.13 million in FY2024 (-10.0%), $14.59 million in FY2023 (-13.4%), $16.84 million in FY2022 (+14.3%) and $14.72 million in FY2021 (+346.6%).
- Quarterly Selling, General & Administrative has ranged from $958,000 in Q3 2025 to $6.21 million in Q2 2022 over the past five years.
- On a year-over-year basis, Selling, General & Administrative rose in 1 of the last eight quarters, with an average decline of 35.2%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 669.4% in Q4 2021, against a decline of 71.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.63 million (Q1 2026), $1.42 million (Q4 2025) and $958,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 3.34 Mn |
| Jun 30, 2022 | 6.21 Mn |
| Mar 31, 2022 | 4.51 Mn |
| Dec 31, 2021 | 4.27 Mn |
API Access
Ernexa Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();